Recently Featured

Thermo Fisher Scientific Opens Cryo-EM Drug Discovery Center in South San Francisco

March 21, 2026
Thermo Fisher Scientific has inaugurated its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center (CDDC) in South San Francisco, a facility aimed at enhancing the capabilities of pharmaceutical and biotechnology companies in drug development. This center offers hands-on access to cutting-edge cryo-EM technologies, which are pivotal for accelerating structural insights and therapeutic advancements. According to a Thermo…

LabVantage Solutions Launches LabVantage CORTEX, Enhancing LIMS with AI-Driven Automation

March 21, 2026
LabVantage Solutions, Inc. has unveiled LabVantage CORTEX, a state-of-the-art artificial intelligence (AI), analytics, and automation platform that marks a significant advancement in the company’s laboratory informatics offerings. This launch integrates sophisticated AI capabilities and enhanced automation into the core LabVantage LIMS experience, aimed at optimizing laboratory operations for improved accuracy and efficiency. As laboratories across…

As AI Evolves, the Modern R&D Lab is Changing

March 20, 2026
As artificial intelligence and automation increasingly influence drug discovery, the design and function of research and development laboratories are undergoing significant transformations. Ryley Poblete from Gensler highlights that the integration of advanced technologies is not only altering how experiments are conducted but also reshaping the composition of scientific teams and their collaborative processes. This evolution…

FDA Places PepGen’s Phase 2 Muscle Disease Trial on Partial Hold

March 20, 2026
The FDA has placed PepGen’s Phase 2 clinical trial for its only pipeline product, a potential therapy targeting a rare genetic muscle disorder, on partial hold. This action comes as the agency raised concerns regarding the product’s previously submitted safety data and its implications for patient health. This partial hold not only delays the trial’s…

Ongoing Cases